Hisamitsu Pharmaceutical Co. Statistics

Total Valuation

Hisamitsu Pharmaceutical Co. has a market cap or net worth of JPY 309.51 billion. The enterprise value is 190.24 billion.

Market Cap	309.51B
Enterprise Value	190.24B

Important Dates

The next estimated earnings date is Friday, January 10, 2025.

Earnings Date	Jan 10, 2025
Ex-Dividend Date	Feb 27, 2025

Share Statistics

Hisamitsu Pharmaceutical Co. has 73.34 million shares outstanding. The number of shares has decreased by -4.02% in one year.

Current Share Class	n/a
Shares Outstanding	73.34M
Shares Change (YoY)	-4.02%
Shares Change (QoQ)	-2.11%
Owned by Insiders (%)	0.73%
Owned by Institutions (%)	44.34%
Float	68.26M

Valuation Ratios

The trailing PE ratio is 21.67 and the forward PE ratio is 18.73.

PE Ratio	21.67
Forward PE	18.73
PS Ratio	2.11
PB Ratio	1.13
P/TBV Ratio	n/a
P/FCF Ratio	985.69
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.54, with an EV/FCF ratio of 605.86.

EV / Earnings	12.99
EV / Sales	1.27
EV / EBITDA	9.54
EV / EBIT	13.35
EV / FCF	605.86

Financial Position

The company has a current ratio of 3.53, with a Debt / Equity ratio of 0.00.

Current Ratio	3.53
Quick Ratio	2.97
Debt / Equity	0.00
Debt / EBITDA	0.06
Debt / FCF	3.56
Interest Coverage	510.30

Financial Efficiency

Return on equity (ROE) is 5.50% and return on invested capital (ROIC) is 3.11%.

Return on Equity (ROE)	5.50%
Return on Assets (ROA)	2.48%
Return on Capital (ROIC)	3.11%
Revenue Per Employee	54.43M
Profits Per Employee	5.31M
Employee Count	2,759
Asset Turnover	0.43
Inventory Turnover	3.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.80%
50-Day Moving Average	4,136.86
200-Day Moving Average	3,962.81
Relative Strength Index (RSI)	44.03
Average Volume (20 Days)	151,295

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hisamitsu Pharmaceutical Co. had revenue of JPY 150.19 billion and earned 14.65 billion in profits. Earnings per share was 194.73.

Revenue	150.19B
Gross Profit	84.73B
Operating Income	13.78B
Pretax Income	20.65B
Net Income	14.65B
EBITDA	19.47B
EBIT	13.78B
Earnings Per Share (EPS)	194.73

Full Income Statement

Balance Sheet

The company has 122.74 billion in cash and 1.12 billion in debt, giving a net cash position of 121.62 billion or 1,658.23 per share.

Cash & Cash Equivalents	122.74B
Total Debt	1.12B
Net Cash	121.62B
Net Cash Per Share	1,658.23
Equity (Book Value)	275.93B
Book Value Per Share	3,730.06
Working Capital	148.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.59 billion and capital expenditures -18.28 billion, giving a free cash flow of 314.00 million.

Operating Cash Flow	18.59B
Capital Expenditures	-18.28B
Free Cash Flow	314.00M
FCF Per Share	4.28

Full Cash Flow Statement

Margins

Gross margin is 56.42%, with operating and profit margins of 9.17% and 9.75%.

Gross Margin	56.42%
Operating Margin	9.17%
Pretax Margin	13.75%
Profit Margin	9.75%
EBITDA Margin	12.96%
EBIT Margin	9.17%
FCF Margin	0.21%

Dividends & Yields

This stock pays an annual dividend of 86.00, which amounts to a dividend yield of 2.03%.

Dividend Per Share	86.00
Dividend Yield	2.03%
Dividend Growth (YoY)	3.24%
Years of Dividend Growth	7
Payout Ratio	44.42%
Buyback Yield	4.02%
Shareholder Yield	6.05%
Earnings Yield	4.61%
FCF Yield	0.10%

Dividend Details

Stock Splits

The last stock split was on June 27, 2000. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2000
Split Type	Forward
Split Ratio	2

Scores

Hisamitsu Pharmaceutical Co. has an Altman Z-Score of 4.65.

Altman Z-Score	4.65
Piotroski F-Score	n/a